Medical meetings - Medical educations

Highly Potent Active Pharmaceutical Ingredients USA

Ref: 29703 10/21/2019 -> 10/22/2019 - Boston ^US

The event will explore how the latest technologies can benefit HPAPI with artificial intelligence and machine learning to hasten risk assessment and validation. We will also be dedicating much deserved attention on emerging  therapies including bispecific antibodies, oncolytic viral ...

Targeted Protein Degradation Summit, October 22-24 2019, Boston, USA

Ref: 29466 10/22/2019 -> 10/24/2019 - Boston ^US

  The 2nd TPD 2019 is a specifically dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to capitalize on the emerging therapeutic class of protein degradation.    As the drug discovery opportunity promised within the proteome ...

Macrophage Directed Therapies Summit 2019

Ref: 29936 10/22/2019 -> 10/24/2019 - Boston ^US

Your comprehensive guide to demonstrating clinical validation of your macrophage therapeutic approach.

Lyophilization USA Conference, October 23-24, Boston, USA

Ref: 29736 10/23/2019 -> 10/24/2019 - Boston ^US

The current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can ...

Neuromuscular Drug Development Summit (NMD)

Ref: 30045 10/23/2019 -> 10/25/2019 - Boston ^US

Following a number of neuromuscular approvals recently, the 2nd Annual NMD meeting will harness the excitement of the field whilst unravelling the complexities of developing safe and effective second generation therapeutics.   Registering for NMD will help you to:   - Optimize ...

Inflammasome Therapeutics Summit

Ref: 30085 10/29/2019 -> 10/31/2019 - Boston ^US

The inaugural Inflammasome Therapeutics Summit (ITS) is industry's first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders.

2019 Diabetic Lower Extremity Symposium

Ref: 30661 11/07/2019 -> 11/08/2019 - Boston ^US

  What is this meeting about?   Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary ...

3rd Microbiome Movement - Human Nutrition Summit

Ref: 30053 11/11/2019 -> 11/13/2019 - Boston ^US

Recent scientific and clinical advances over the past decade have identified the trillions of microbial cells that reside in the gut, collectively known as the gut microbiome, as a key regulator of human health and disease. This rapid rise in interest for the gut microbiome has permeated beyond ...

15th Annual Personalized Medicine Conference at Harvard Medical School

Ref: 29812 11/13/2019 -> 11/14/2019 - Boston ^US

The 15th Annual Personalized Medicine Conference at Harvard Medical School will explore the science, business, and policy issues facing personalized medicine as scientists refine their understanding of how groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data ...

3rd Complement-based Drug Development Summit 2019

Ref: 30175 11/13/2019 -> 11/15/2019 - Boston ^US

The only industry dedicated complement therapeutics meeting. Optimize novel pathway targeting, assay validation and clinical translation to drive complement inhibition development.

3rd Annual AFDD Summit

Ref: 30181 11/18/2019 -> 11/20/2019 - Boston ^US

    With 3 days of in-depth cutting-edge case studies and the highest calibre of industry and academic discussions, 3rd Anti-fibrotic Drug Development Summit (AFDD) will provide the roadmap to anti-fibrotic drug development success. Hear from pharma and biotech companies of all ...

1st RNA Editing Summit 2019

Ref: 30216 11/19/2019 -> 11/20/2019 - Boston ^US

RNA Editing Summit is the first industry led meeting focused on the recent developments of RNA editing mechanisms. Translating Emerging RNA Editing Approaches for Therapeutic Applications.

Gene Therapy Analytical Development | November 19-21 | Boston, MA

Ref: 30308 11/19/2019 -> 11/21/2019 - Boston ^US

In the context of unprecedented gene therapy clinical progress and mounting regulatory scrutiny, the inaugural Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene ...

3rd Annual Dermatology Drug Development Summit US

Ref: 30341 11/19/2019 -> 11/21/2019 - Boston ^US

  The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need. The dermatology ...

4th Computational Drug Development for Biologics

Ref: 30464 11/19/2019 -> 11/21/2019 - Boston ^US

Harnessing the Additive Power of In Silico Tools for Biologics Development

NeoAg Summit

Ref: 30178 11/20/2019 -> 11/22/2019 - Boston ^US

The 4th NeoAg Summit is your comprehensive guide to targeting tumor-specific neoantigens and bringing to market personalized cancer vaccines and cellular therapies.

2nd RNA- Targeted Drug Discovery Summit

Ref: 30185 12/02/2019 -> 12/04/2019 - Boston ^US

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 2nd RNA- Targeted Drug Discovery Summit returns to reunite the leading minds from large pharma, innovative biotech and KOLs of academia to discuss unique discovery and development challenges that ...

LEAP TA: Life Sciences 2019

Ref: 30393 12/03/2019 -> 12/04/2019 - Boston ^US

  LEAP TA: Life Sciences is a unique opportunity designed for anyone with a stake in talent acquisition at the heart of biopharma businesses of all sizes. Regardless of the size or state of your life sciences organization, this is the only forum committed to examining the genuine ...

Oncolytic Virotherapy Summit

Ref: 30424 12/03/2019 -> 12/05/2019 - Boston ^US

Optimize the Immune Response to Cancer with Viral Vehicles. The roadmap to oncolytic virotherapy success

3rd Microbiome Movement - Gut-Brain Axis Summit - December, Boston

Ref: 30506 12/03/2019 -> 12/05/2019 - Boston ^US

  As scientific researchers continue to investigate the complexities of the microbiome-gut brain communication highway, our mission for the 3rd Microbiome Movement - Gut-Brain Axis Summit is simple: Unite pioneering industry and academic researchers to establish the mechanistic pathways ...

Clinically Validated Digital Therapeutics Summit

Ref: 30242 12/04/2019 -> 12/05/2019 - Boston ^US

Uniting pharma, DTx companies and healthcare institutions, the Clinically Validated DTx Summit is solely focused on the actionable uses of digital therapeutics to deliver radically improved patient outcomes.   Rapid developments in the field come with deep challenges, from navigating the ...

Gene Therapy for Neurological Disorders

Ref: 30451 12/10/2019 -> 12/12/2019 - Boston ^US

60+ industry stakeholders will meet at GTxN to overcome the translational challenges of developing gene therapies targeting neurological disorders.

Glioblastoma Drug Development Summit 2019

Ref: 30546 12/10/2019 -> 12/11/2019 - Boston ^US

Accelerate the Discovery, Translation & Clinical Development of Safe, Effective & Deliverable Therapies to Patients in Need

Commercializing Continuous Processing in Pharma

Ref: 30576 01/28/2020 -> 01/30/2020 - Boston ^US

Safety, Efficacy, Efficiency and Quality: Scaling Your Continuous Processing from Technology to Commercial Manufacturing   Four years in the drug development world isn’t long, and the progress made in continuous processing has been an extraordinary. Thanks to the encouragement of the FDA ...

PARP & DDR Inhibitors Summit 2020

Ref: 30694 01/28/2020 -> 01/30/2020 - Boston ^US

  In January 2020 the Chiefs, Heads and Directors of the DNA Damage Response field will gather at the PARP & DNA Damage Response (DDR) Inhibitors Summit to push PARP into wider indications and accelerate novel target development. Hear from experts at Merck KGaA, Bayer, AstraZeneca and ...